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Background: Studies have indicated that an early invasive strategy is favorable over a selective 
invasive strategy for Non-ST segment elevation acute coronary syndromes (NSTE-ACS). 
However, there is no general consensus on precisely how early should the revascularization 
be performed. Randomized controlled trials (RCTs) performed to compare the outcomes of 
revascularization less than 24 hours of presentation (Group A) versus greater than 24 hours of 
presentation (Group B) for NSTE-ACS have shown conflicting results. 
Methods: Based on a systematic search seven RCTs (13,762 patients) comparing the composite 
of death and myocardial infarctions (MI) within 30 days of revascularization were included. The 
effects of both methods were analyzed by calculating pooled estimates for composite of death 
and MI, death, MI and revascularization.
Results: The incidence of the composite of death and MI was noted be lower in group A 
[607/7710(7.8%)] compared to group B [822/6052(13.5%)] but this was not statistically 
significant (OR 0.83, 95% CI, 0.62-1.12, P=0.22). Similar results were obtained for death (OR 
0.58, 95% CI, 0.24-1.39) and MI (OR 0.93, 95% CI, 0.64-1.34) separately. In group A there 
was a significant decrease in the incidence of repeat revascularization [405/7398(5.5%)] as 
compared to group B [336/5734(5.9%)] [OR 1.34, 95% CI, 1.14-1.56, P<0.0003]. Two studies 
showed mortality benefit in high risk (TIMI score≥5-7, GRACE score>140) patients undergoing 
revascularization within 24 hours. 
Conclusions: Performance of coronary artery revascularization within 24 hours of presentation 
does not reduce death and MI in NSTE-ACS as compared to intervention after 24 hours, but does 
significantly reduce the rate of repeat revascularization.
